您的位置: 首页 > 农业专利 > 详情页

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY
专利权人:
CANCER RESEARCH TECHNOLOGY LIMITED;ASTEX THERAPEUTICS LIMITED
发明人:
CHESSARI, Gianni,HOWARD, Steven,BUCK, Ildiko Maria,CONS, Benjamin David,JOHNSON, Christopher Norbert,HOLVEY, Rhian Sara,REES, David Charles,ST. DENIS, Jeffrey David,TAMANINI, Emiliano,GOLDING, Bernard
申请号:
PH12018500626
公开号:
PH12018500626A1
申请日:
2018.03.22
申请国别(地区):
PH
年份:
2018
代理人:
摘要:
The invention provides a compound of formula (I): (I) or tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the various substituents are as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充